换一批Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit.
第一作者：
Douglas,Grossman
第一单位：
Huntsman Cancer Institute, Salt Lake City, Utah.;Department of Dermatology, University of Utah, Salt Lake City.;Department of Oncological Sciences, University of Utah, Salt Lake City.
作者：
Douglas,Grossman [1]
;
Nwanneka,Okwundu [2]
;
Edmund K,Bartlett [3]
;
Michael A,Marchetti [4]
;
Megan,Othus [5]
;
Daniel G,Coit [3]
;
Rebecca I,Hartman [6]
;
Sancy A,Leachman [7]
;
Elizabeth G,Berry [7]
;
Larissa,Korde [8]
;
Sandra J,Lee [9]
;
Menashe,Bar-Eli [10]
;
Marianne,Berwick [11]
;
Tawnya,Bowles [12]
;
Elizabeth I,Buchbinder [13]
;
Elizabeth M,Burton [14]
;
Emily Y,Chu [15]
;
Clara,Curiel-Lewandrowski [16]
;
Julia A,Curtis [17]
;
Adil,Daud [18]
;
Dekker C,Deacon [17]
;
Laura K,Ferris [19]
;
Jeffrey E,Gershenwald [14]
;
Kenneth F,Grossmann [20]
;
Siwen,Hu-Lieskovan [20]
;
John,Hyngstrom [21]
;
Joanne M,Jeter [22]
;
Robert L,Judson-Torres [23]
;
Kari L,Kendra [22]
;
Caroline C,Kim [24]
;
John M,Kirkwood [25]
;
David H,Lawson [26]
;
Philip D,Leming [27]
;
Georgina V,Long [28]
;
Ashfaq A,Marghoob [4]
;
Janice M,Mehnert [29]
;
Michael E,Ming [15]
;
Kelly C,Nelson [30]
;
David,Polsky [31]
;
Richard A,Scolyer [32]
;
Eric A,Smith [33]
;
Vernon K,Sondak [34]
;
Mitchell S,Stark [35]
;
Jennifer A,Stein [31]
;
John A,Thompson [36]
;
John F,Thompson [37]
;
Suraj S,Venna [38]
;
Maria L,Wei [39]
;
Susan M,Swetter [40]
作者单位：
Huntsman Cancer Institute, Salt Lake City, Utah.;Department of Dermatology, University of Utah, Salt Lake City.;Department of Oncological Sciences, University of Utah, Salt Lake City.
[1]
Huntsman Cancer Institute, Salt Lake City, Utah.
[2]
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
[3]
Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
[4]
Fred Hutchinson Cancer Research Center, Seattle, Washington.
[5]
Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.;Department of Dermatology, Harvard Medical School, Boston, Massachusetts.
[6]
Department of Dermatology and Knight Cancer Institute, Oregon Health & Science University, Portland.
[7]
Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.
[8]
Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.;Department of Data Sciences, Harvard Medical School, Boston, Massachusetts.
[9]
Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston.
[10]
Departments of Dermatology and Internal Medicine, University of New Mexico Cancer Center, University of New Mexico, Albuquerque.
[11]
Department of Surgery, Division of Surgical Oncology, University of Utah, Salt Lake City.
[12]
Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.;Department of Internal Medicine, Harvard Medical School, Boston, Massachusetts.
[13]
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
[14]
Department of Dermatology, Perelman School of Medicine University of Pennsylvania, Philadelphia.
[15]
Department of Dermatology and University of Arizona Cancer Center, University of Arizona, Tucson.
[16]
Department of Dermatology, University of Utah, Salt Lake City.
[17]
Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco.;Department of Hematology/Oncology, University of California, San Francisco.
[18]
Department of Dermatology and University of Pittsburgh Clinical and Translational Science Institute, Pittsburgh, Pennsylvania.
[19]
Huntsman Cancer Institute, Salt Lake City, Utah.;Department of Medicine, Division of Oncology, University of Utah, Salt Lake City.
[20]
Huntsman Cancer Institute, Salt Lake City, Utah.;Department of Surgery, Division of Surgical Oncology, University of Utah, Salt Lake City.
[21]
Department of Internal Medicine and The Ohio State University Comprehensive Cancer Center, Columbus.
[22]
Huntsman Cancer Institute, Salt Lake City, Utah.;Department of Dermatology, University of Utah, Salt Lake City.
[23]
Department of Dermatology, Tufts Medical Center, Boston, Massachusetts.;Partners Healthcare, Newton Wellesley Dermatology Associates, Wellesley, Massachusetts.
[24]
Department of Internal Medicine and UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania.
[25]
Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, Georgia.
[26]
Cincinnati Cancer Advisors, Cincinnati, Ohio.
[27]
Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.;Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.;Department of Medical Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australia.;Charles Perkins Centre, The University of Sydney, Sydney, Australia.
[28]
Department of Medical Oncology, Robert Wood Johnson University Hospital, New Brunswick, New Jersey.;Rutgers Cancer Institute of New Jersey, New Brunswick.
[29]
Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston.
[30]
Department of Dermatology, Ronald O. Perelman Department of Dermatology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York University School of Medicine, New York, New York.
[31]
Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.;Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.;Charles Perkins Centre, The University of Sydney, Sydney, Australia.;Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.
[32]
Department of Pathology, University of Utah, Salt Lake City.
[33]
Department of Cutaneous Oncology, Moffitt Cancer Center & Research Institute, Tampa, Florida.;Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa.
[34]
The University of Queensland Diamantina Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Australia.
[35]
Fred Hutchinson Cancer Research Center, Seattle, Washington.;Department of Oncology, University of Washington, Seattle.;Seattle Cancer Care Alliance, Seattle, Washington.
[36]
Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.;Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.;Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
[37]
Inova Schar Cancer Institute, Department of Medicine, Virginia Commonwealth University, Fairfax.
[38]
Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco.;Department of Dermatology, University of California, San Francisco.;Dermatology Service, Veterans Affairs Medical Center, San Francisco, California.
[39]
Stanford University Medical Center and Cancer Institute, Stanford, California.;Dermatology Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
[40]
医学主题词
多数赞同(Consensus);总结性报告(主题)(Consensus Development Conferences as Topic);基因表达谱(Gene Expression Profiling);人类(Humans);黑色素瘤(Melanoma);肿瘤分期(Neoplasm Staging);诊疗准则(主题)(Practice Guidelines as Topic);预后(Prognosis);前哨淋巴结活组织检查(Sentinel Lymph Node Biopsy);皮肤肿瘤(Skin Neoplasms)
DOI
10.1001/jamadermatol.2020.1729
PMID
32725204
发布时间
2024-05-25
- 浏览0
JAMA dermatology
JAMA dermatology
2020年156卷9期
1004-1011页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
